News

Research into rare blood cancers called myeloproliferative neoplasms goes global

MPN News | 12/4/19

MPN advocacy organizations are working together across borders to ensure that people living with polycythemia vera, essential thrombocythemia and myelofibrosis will have their treatment needs met by investing in research.

Read More

"Introducing the Targeted Anticancer Therapies and Precision Medicine in Cancer Collection"

MPN News | 11/22/19
Read More

Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis

MPN News | 11/21/19

Sierra Oncology announced today that it has launched the Phase 3 MOMENTUM clinical trial for Myelofibrosis patients

Read More

Call for MPN drug to be approved in Australia

MPN News | 11/20/19

"There's actually an even longer-acting version of the drug, an ultra-long-acting version, which has been approved in Europe but not Australia, and we'd like to see that approved here."

Read More

Pegylated Interferon Benefits High-Risk MPNs Previously Treated With Hydroxyurea

MPN News | 11/07/19

According to a study published in Blood, Pegylated interferon proved to be effective for patients with high-risk ET and PV.

Read More

New Clinical Trials Available for MPN Patients

MPN News | 11/06/19

Vactosertib and PRT543 are now available.

Read More

Patient Power's MPN Patient Survey

MPN News | 10/21/19

As researchers around the world seek to accelerate progress in medicine it's important for patients to share their stories to promote greater understanding. Patient Power has partnered with Dr. Naveen Pemmaraju to find out more about how patients use online resources to guide their car

Read More

New Trial Recruiting Primary, Post-PV, and Post-ET Myelofibrosis Patients

MPN News | 10/15/19

CTI Biopharma is recruiting patients for the PACIFCA trial, a randomized phase 3 study evaluating PACRITINIB in patients with MF.

Read More

The Fall 2019 Newsletter is Here

MPN News | 10/3/19

Your copy of the Fall 2019 Newsletter from the MPN Research Foundation is now available.

Read More

Pegylated Interferon Leads to High Response Rates in ET & PV After Hydroxyurea

MPN News | 10/1/19

ASH Clinical News reports on the results of an open-label, phase II clinical trial published in Blood.

Read More

Today is Rare Cancer Day!

MPN News | 10/1/19

The big day is here - Rare Cancer Day! Launched by the National Organization for Rare Disorders (NORD) and the NORD Rare Cancer Coalition, the goal of #RareCancerDay is to raise critical awareness of rare cancers and the need for greater research funding and patient support.

Read More

Geron Receives Fast Track Designation to Imetelstat for Myelofibrosis

MPN News | 9/30/19

More possible good news for upcoming therapies for myeloproliferative neoplasms. Geron was granted fast-track designation by FDA for imetelstat, which they have pursued in people with Intermediate-2 Myelofibrosis

Read More

MPN Research Foundation Announces 2019-2020 Grantees for MPN Challenge Grant program

MPN News | 9/23/19

The MPN Research Foundation is thrilled to announce the award of seven new projects as part of the MPN Challenge Grant program, a partnership between MPNRF and The Leukemia & Lymphoma Society. The following projects applied and reviewed in a competitive, peer-reviewed process that took place this past July in Chicago.

Read More

Pegasys users may now access resources to help with reimbursement issues through Genentech

MPN News | 9/10/19

For more information about the Genentech Patient Foundation and to learn if a patient receiving a Genentech product (such as Pegasys) is eligible to receive support, please visit www.gene.com/patients/patient-foundation or call the Patient Resource Center at 877-GENENTECH.

Read More

Patient Advocates Take Aim at Progression in Myeloproliferative Neoplasms

MPN News | 9/10/19

Through a one-year pilot grant, the MPN Research Foundation (MPNRF) will provide funding to Dr. Ann Mullally and Dana-Farber Cancer Institute's Center for Prevention of Progression (CPOP) to study the genomic basis for MPN disease progression

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?